Cited by 574SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesSARS-CoV-2 detection and testing

Evolution and epidemic spread of SARS-CoV-2 in Brazil

Open access
Candido, Darlan S., Claro, Ingra M., de Jesus, Jaqueline G., Souza, William M., Moreira, Filipe R. R., Dellicour, Simon, Mellan, Thomas A., du Plessis, Louis +71 more·2020·Science

Published version of a preprint

Abstract

The spread of SARS-CoV-2 in Brazil: Brazil has been hard-hit by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Candido et al. combined genomic and epidemiological analyses to investigate the impact of nonpharmaceutical interventions (NPIs) in the country. By setting up a network of genomic laboratories using harmonized protocols, the researchers found a 29% positive rate for SARS-CoV-2 among collected samples. More than 100 international introductions of SARS-CoV-2 into Brazil were identified, including three clades introduced from Europe that were already well established before the implementation of NPIs and travel bans. The virus spread from urban centers to the rest of the country, along with a 25% increase in the average distance traveled by air passengers before travel bans, despite an overall drop in short-haul travel. Unfortunately, the evidence confirms that current interventions remain insufficient to keep virus transmission under control in Brazil. Science , this issue p. 1255

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.abd2161

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Viral genetic diversity, evolution, variable infectivity, or co-pathogenesis might contribute to infectivity and fatality but not much to COVID-19 disease heterogeneity.

    “Numerous mutations identified so far by thousands of viral sequences obtained during the first 9 months of the pandemic (Candido et al., 2020; Oude Munnink et al., 2020) suggest that viral genetic diversity, genetic evolution, variable infectivity, or co-pathogenesis might contribute to infectivity and fatality, but not so much to disease heterogeneity observed for COVID-19.”

    From COVID-19 and the human innate immune system (2021) · cites this paper as Candido et al., 2020

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Candido, D. S., Claro, I. M., de Jesus, J. G., Souza, W. M., Moreira, F. R. R., Dellicour, S., Mellan, T. A., du Plessis, L., Pereira, R. H. M., Sales, F. C. S., Manuli, E. R., Thézé, J., Almeida, L., Menezes, M. T., Voloch, C. M., Fumagalli, M. J., Coletti, T. M., da Silva, C. A. M., Ramundo, M. S., Amorim, M. R., Hoeltgebaum, H. H., Mishra, S., Gill, M. S., Carvalho, L. M., Buss, L. F., Prete, C. A., Ashworth, J., Nakaya, H. I., Peixoto, P. S., Brady, O. J., Nicholls, S. M., Tanuri, A., Rossi, Á. D., Braga, C. K. V., Gerber, A. L., de C. Guimarães, A. P., Gaburo, N., Alencar, C. S., Ferreira, A. C. S., Lima, C. X., Levi, J. E., Granato, C., Ferreira, G. M., Francisco, R. S., Granja, F., Garcia, M. T., Moretti, M. L., Perroud, M. W., Castiñeiras, T. M. P. P., Lazari, C. S., Hill, S. C., de Souza Santos, A. A., Simeoni, C. L., Forato, J., Sposito, A. C., Schreiber, A. Z., Santos, M. N. N., de Sá, C. Z., Souza, R. P., Resende-Moreira, L. C., Teixeira, M. M., Hubner, J., Leme, P. A. F., Moreira, R. G., Nogueira, M. L., Brazil-UK Centre for Arbovirus Discovery, D., Ferguson, N. M., Costa, S. F., Proenca-Modena, J. L., Vasconcelos, A. T. R., Bhatt, S., Lemey, P., Wu, C.-H., Rambaut, A., Loman, N. J., Aguiar, R. S., Pybus, O. G., Sabino, E. C., & Faria, N. R.
Affiliations
  • Department of Zoology, University of Oxford, Oxford, UK.
  • Universidade de São Paulo (BR)
  • Instituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Centro de Pesquisa em Virologia, Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, Brazil.
  • Universidade Federal do Rio de Janeiro (BR)
  • Université Libre de Bruxelles (BE)
  • Imperial College London (GB)
  • Institute of Applied Economic Research (BR)
  • Université Clermont Auvergne (FR)
  • Universidade Estadual de Campinas (UNICAMP) (BR)
  • Fundação Getulio Vargas (BR)
  • Rega Institute for Medical Research (BE)
  • Department of Electronic Systems Engineering, University of São Paulo, São Paulo, Brazil.
  • London School of Hygiene & Tropical Medicine (GB)
  • University of Birmingham (GB)
  • Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Laboratório de Bioinformática, Laboratório Nacional de Computação Científica, Petrópolis, Brazil.
  • Instituto Hermes Pardini, Belo Horizonte, Brazil.
  • Universidade Federal de Minas Gerais (BR)
  • Fleury S.A. (Brazil) (BR)
  • Universidade Federal de Roraima (BR)
  • Divisão de Doenças Infecciosas, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, Brazil.
  • Hospital Estadual Sumaré, Universidade Estadual de Campinas, Campinas, Brazil.
  • Royal Veterinary College (GB)
  • University of Oxford, Latin American Centre, Oxford School of Global and Area Studies, Oxford, UK.
  • Departamento de Patologia Clínica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, Brazil.
  • Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Departamento de Biologia Celular, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Centro de Saúde da Comunidade, Universidade Estadual de Campinas, Campinas, Brazil.
  • Faculdade de Medicina de São José do Rio Preto (BR)
  • Departamento de Genética, Evolução, Microbiologia e Imunologia, Instituto de Biologia, Universidade Estadual de Campinas, Campinas, Brazil.
  • University of Southampton (GB)
  • University of Edinburgh (GB)
  • Institute for Microbiology and Infection, University of Birmingham, Birmingham, UK.
Corresponding author
Faria, Nuno Rodrigues
Venue
Science
Published
2020-09-04
Volume
369
Issue
6508
Pages
1255-1260
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W3044468596
Cited by
573
References
69
Citations by year
2026: 6 · 2025: 32 · 2024: 46 · 2023: 61 · 2022: 133 · 2021: 227 · 2020: 68
FWCI
16.04
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • HAL (submittedVersion, other-oa)
  • Lirias (submittedVersion, cc-by)
  • RVC Research Online (Royal Veterinary College) (submittedVersion, cc-by)
  • Lirias (submittedVersion, cc-by-nc-nd)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
Funders
  • Medical Research Council (MR/S0195/1)
  • São Paulo Research Foundation (MR/S0195/1)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
Keywords
SARS-CoV-2, COVID-19 epidemic, Brazil, non-pharmaceutical interventions, reproduction number, viral genome sequencing, air travel, viral evolution, São Paulo, Rio de Janeiro
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Testing, Bayes Theorem, Brazil, Cities, Europe, Humans, Models, Genetic, Phylogeny, Pneumonia, Viral, Travel, Urban Population, Models, Statistical, Genome, Viral, Coronavirus Infections, Evolution, Molecular, Clinical Laboratory Techniques, Basic Reproduction Number, Pandemics, Phylogeography, Spatio-Temporal Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review